Stomach Cancer Trial, Recruiting NCT06475170 Sponsor: Northern Jiangsu People's Hospital Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT06475170
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 75 years old (male or female)
  • A tissue sample (biopsy) taken before surgery has confirmed you have stomach cancer located in the upper third of the stomach (including where the stomach meets the food pipe)
  • Your cancer is at an early stage (Stage Ia or Ib, meaning it has not spread extensively into surrounding tissue or lymph nodes)
  • Scans and imaging taken before surgery (chest X-ray, abdominal ultrasound, or CT scan) show the cancer has not spread to distant parts of the body
  • You have been assessed as fit enough for surgery (rated ASA grade 1, 2, or 3 by your medical team)
  • You have no medical reasons that would prevent you from having surgery
  • You and your family are willing to voluntarily sign a consent form to take part in the study

Who may not be able to join:

  • You have been diagnosed with another primary cancer elsewhere in the body, or the cancer has spread to distant organs
  • Your stomach tumor is located on the greater curvature (the outer, longer curve) of the stomach
  • You have a blood clotting disorder that cannot be treated or corrected
  • You have been diagnosed with viral hepatitis or liver cirrhosis
  • You have diabetes, whether uncontrolled or managed with insulin
  • You have serious failure of major organs, such as the heart, lungs, liver, brain, or kidneys
  • You have fluid build-up in your abdomen (ascites) or significant unintended weight loss and muscle wasting (cachexia) before surgery
  • You have a condition that weakens your immune system, or you take medications that suppress your immune system, or you have an autoimmune disease (such as lupus, or have had a bone marrow transplant) (confirm with trial site)
  • You are unwilling to sign the study consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 18051062590

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Northern Jiangsu People's Hospital
Registry
ClinicalTrials.gov
Start date
1 August 2024
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

incidence of reflux esophagitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov